-transparent.png){kind=logo}
The tolerance and anti-hypertensive activity of nicergoline, an alpha-adrenoceptor blocking agent, were studied in 28 hypertensive subjects older than 65 years (mean age: 84 years). The trial was conducted double-blind: 14 subjects were given nicergoline 30 mg/day divided into 6 doses ("lyocs"), and 14 subjects received a placebo identical in appearance with the drug. A mean decrease of 34 mm Hg in systolic arterial pressure (p < 0.001) and of 16 mm Hg in diastolic arterial pressure (p < 0.001) was observed in subjects under nicergoline. The corresponding changes in blood pressure (-12 and -7.9 mm Hg respectively) in subjects under placebo were not significant. No side-effect requiring discontinuation of treatment was encountered. The remarkable effectiveness and tolerance of nicergoline make it a highly suitable agent for the treatment of hypertension in elderly people.
F Forette, and
D Varin, and
J F Henry, and
M P Hervy
April 1977,
Deutsche medizinische Wochenschrift (1946),
F Forette, and
D Varin, and
J F Henry, and
M P Hervy
September 1979,
La Nouvelle presse medicale,
F Forette, and
D Varin, and
J F Henry, and
M P Hervy
January 1983,
Therapie,
F Forette, and
D Varin, and
J F Henry, and
M P Hervy
January 1974,
Current medical research and opinion,
F Forette, and
D Varin, and
J F Henry, and
M P Hervy
November 1979,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
F Forette, and
D Varin, and
J F Henry, and
M P Hervy
May 1981,
Der Urologe. Ausg. A,
F Forette, and
D Varin, and
J F Henry, and
M P Hervy
January 1978,
Acta cientifica venezolana,
F Forette, and
D Varin, and
J F Henry, and
M P Hervy
November 1984,
Revue francaise de gynecologie et d'obstetrique,
F Forette, and
D Varin, and
J F Henry, and
M P Hervy
January 1979,
Annales de cardiologie et d'angeiologie,
F Forette, and
D Varin, and
J F Henry, and
M P Hervy
March 1996,
Minerva cardioangiologica,
